Targeting protein may help control body's internal clock

Image
Press Trust of India Washington
Last Updated : Dec 26 2014 | 3:15 PM IST
Targeting a protein which appears to play a key role in regulating mammals' internal clock may help treat sleep and anxiety disorders, scientists say.
Thomas Burris, chair of pharmacological and physiological science at Saint Louis University, and his colleagues examined compounds that target a protein called REV-ERB.
"It has been suggested that REV-ERB is a core component of our clock," said Burris.
"Mice without it are arrhythmic. This study demonstrated that when we give mice a synthetic compound that turns REV-ERB on, it altered their circadian rhythm," Burris said.
Circadian rhythm refers to biological processes that cycle every 24 hours. In mammals, the internal clock that maintains circadian rhythm is essential for normal physiological functions.
The rhythms can, however, be disrupted, and dysregulation of circadian rhythm is associated with many disorders, including metabolic disease and neuropsychiatric disorders including bipolar disorder, anxiety, depression, schizophrenia and sleep disorders.
The team examined effects of the REV-ERB drug on patterns of sleep and wakefulness and found that the compound increases wakefulness, reduces REM and slow-wave sleep, and, notably, decreases anxiety.
This is an interesting finding because it is unusual, researchers said. Frequently, drugs that increase arousal (wakefulness) also increase anxiety and drugs that decrease anxiety also decrease arousal. An exception to this common pattern is nicotine.
The REV-ERB drug, on the other hand, appears to target the clock in a way that is distinct from these common pathways.
Further, the REV-ERB drug appears to be associated with a suppression of reward-seeking behaviour.
Drug addiction has a circadian component and mice with mutations in "clock genes" (genes that affect our internal clocks) have altered responsiveness to the reward associated with cocaine, morphine and alcohol.
Burris speculated that REV-ERB targeted drug effect on the clock would modulate reward-seeking behaviour, and so may be useful in treating addiction.
The research is published in the journal Nature Communications.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 26 2014 | 3:15 PM IST

Next Story